Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
Tilray Brands Inc. (TLRY) maintains a dynamic presence in global cannabis markets through its medical research initiatives and consumer product innovations. This resource provides investors and industry observers with centralized access to verified corporate announcements, regulatory developments, and market analysis.
Users will find updates spanning earnings reports, international expansion efforts, and product portfolio enhancements, including developments in cannabis-infused wellness solutions. The curated selection enables stakeholders to track operational milestones across Tilray's pharmaceutical-grade production facilities and lifestyle brand divisions.
All content undergoes strict verification to ensure alignment with financial disclosure standards and industry regulations. Regular updates reflect Tilray's position as a GMP-certified producer serving medical markets in 20+ countries while expanding recreational offerings in emerging markets.
Bookmark this page for streamlined monitoring of Tilray's strategic initiatives, quality control advancements, and responses to evolving cannabis legislation worldwide.
Tilray has announced the launch of Aphria-branded medical cannabis oral strips in Canada, featuring THC and CBD-rich options. Utilizing QuickStrip™ technology, these strips deliver micronized cannabinoids that dissolve quickly, offering a fast-acting and precise dosing method. Available in different ratios, each pack contains 30 individually wrapped strips. The company emphasizes its commitment to patient wellness and innovation in medical cannabis products as it positions itself in a growing market.
High Tide has completed its acquisition of an 80% interest in NuLeaf Naturals for
Tilray, a global leader in cannabis, is advancing a growth strategy with a focus on EU, Canada, and U.S. markets. In fiscal 2021, it reported $513 million in revenue, a 27% increase, and positive Adjusted EBITDA. CEO Irwin D. Simon aims for $4 billion in revenue by fiscal 2024, driven by a strong EU presence and brand leadership in Canada. The company forecasts $1 billion from the EU and maintains a 30% market share target in Canada. Recent developments in Germany's legalization efforts position Tilray for significant growth opportunities in recreational cannabis.
High Tide Inc. has announced a definitive agreement to acquire 80% of NuLeaf Naturals for
Tilray invites stockholders to its Annual Meeting on November 22, 2021, at 11:00 a.m. EST, to be held virtually due to the ongoing COVID-19 pandemic. The record date for eligible stockholders was September 24, 2021. All shareholders are encouraged to vote and submit proxies if they have not done so. For those attending, a control number is required to join and participate in discussions and voting during the meeting. Tilray, operational in over 20 countries, is a leading cannabis and consumer goods company dedicated to enhancing the well-being of its consumers.
Tilray, a leader in cannabis research and production, has announced its participation in two significant investor conferences organized by Jefferies. The events are scheduled for:
- November 16, 2021, at the Jefferies Virtual West Coast Consumer Conference, starting at 2:00 PM ET.
- November 17, 2021, at the Jefferies London Healthcare Conference, beginning at 11:20 AM ET.
Investors can find more details in the Investors section of Tilray's website.
Tilray has launched SweetWater RIFF, an exclusive ready-to-drink cocktail in a can, marking SweetWater's entry into the spirits category. The new product features two flavors: SweetWater RIFF Citrus and SweetWater RIFF Strawberry Mule, both crafted with vodka and real fruit juices. Each drink contains only 105 calories and is being rolled out in select U.S. grocery and liquor stores. This collaboration showcases the innovative spirit of both SweetWater and RIFF, aiming to provide a premium alternative to traditional cocktails.
Tilray, a leader in medical cannabis, has been designated as a trusted supplier of GMP-certified cannabis to the Luxembourg Ministry of Health. This selection allows Tilray to offer various pharmaceutical-grade products in Luxembourg, enhancing patient access under physician supervision. CEO Irwin D. Simon highlighted a potential $1 billion growth opportunity in the European market. With this announcement, Tilray now provides medical cannabis in 20 countries globally, underscoring its commitment to high-quality standards and expanding its global footprint.
Tilray, a leading global cannabis-lifestyle company, has entered a national brokerage agreement with Great North Distributors, enhancing its market presence in Canada. Great North will exclusively manage Tilray's adult-use cannabis products, excluding Quebec. This partnership aims to boost sales across Canada by leveraging Great North's established retail relationships and data analytics capabilities. CEO Irwin D. Simon stated that this agreement will improve route-to-market efficiencies and drive growth, capitalizing on Great North's coast-to-coast coverage and expertise.
High Tide Inc. has transitioned all Canna Cabana retail cannabis stores to a discount club model, enhancing its presence in the value segment and claiming the title of North America's largest cannabis discount retailer. The Cabana Club loyalty program offers exclusive low prices and benefits to over 245,000 members. This strategy aims to capture market share from the illicit cannabis sector, which accounts for 40% of sales, and reflects a successful pilot program that showed significant sales increases. High Tide plans to expand this model across Canada and potentially globally, leveraging its in-house brands.